Brief: KYORIN Holdings to transfer unit to Taisho Pharmaceutical
Dec 26 (Reuters) - KYORIN Holdings Inc 4569.T :
* Says it to transfer its Japan-based unit Dr.Program to
Taisho Pharmaceutical Co., Ltd that is a unit of Taisho
Pharmaceutical Holdings Co Ltd 4581.T
* Transaction price is not disclosed
* Says the transaction planned effective on April 1, 2017
Source text in Japanese: https://goo.gl/Jmb0e2
Further company Coverage: 4569.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: qiujing.li.thomsonreuters.com@reuters.net))
Recent news on Taisho Pharmaceutical Holdings Co
See all newsBrief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Squeeze Out Price If Taisho Disagrees With Their Demand - Nikkei
Brief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Tender Offer Price If Taisho Disagrees Their Demand - Nikkei
Activist fund Oasis says it may take legal action over Taisho's management buyout
Brief: Curi RMB Capital Opposes Taisho Pharmaceutical HD's Management Buyout
To Retire Treasury Shares Worth 3.65% Of Outstanding Stock On April 10